Waleed Haso

Waleed Haso is currently a Director at Kite Pharma, a biotechnology company focused on cancer immunotherapy, particularly utilizing chimeric antigen receptor (CAR) T-cell therapies. He has been in this role for approximately two years, having previously served as an Associate Director within the same organization.23

Education and Expertise

Waleed Haso holds a degree from The Johns Hopkins University, which underscores his strong educational background in the field of immunotherapy and cancer treatment.1 His expertise specifically lies in the development and application of CAR-engineered T cells, making him a key player in advancing innovative cancer therapies.

Professional Background

Before his current position, Haso accumulated significant experience in various roles at Kite Pharma, contributing to the company's mission of transforming cancer treatment through groundbreaking science.23 His professional journey highlights a commitment to improving patient outcomes through advanced therapeutic strategies.

For further details about his professional profile, you can visit his LinkedIn page here .1